CarelonRx — Cost of products sold
Elevance Health CarelonRx — Cost of products sold decreased by 8.1% to $9.83B in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 5.9%, from $9.28B to $9.83B. Over 3 years (FY 2022 to FY 2025), CarelonRx — Cost of products sold shows an upward trend with a 14.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
Analysis
How to read this metric
Rising costs relative to revenue may indicate supply chain inflation or unfavorable drug pricing, while stable or falling costs suggest effective procurement and supply chain management.
Detailed definition
The direct costs associated with the procurement and distribution of pharmaceutical products sold by the CarelonRx segme...
Peer comparison
Comparable to cost of goods sold (COGS) for pharmacy retail or mail-order operations at major pharmacy benefit managers.
elv_segment_carelonrx_cost_of_products_soldHistorical Data
| Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $6.64B | $6.64B | $6.64B | $6.64B | $7.90B | $7.90B | $7.90B | $7.90B | $7.37B | $8.04B | $8.34B | $9.23B | $9.28B | $9.88B | $10.21B | $10.70B | $9.83B |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +19.0% | +0.0% | +0.0% | +0.0% | -6.6% | +9.0% | +3.7% | +10.7% | +0.6% | +6.5% | +3.3% | +4.8% | -8.1% |
| YoY Change | — | — | — | — | +19.0% | +19.0% | +19.0% | +19.0% | -6.6% | +1.8% | +5.6% | +16.9% | +25.9% | +22.9% | +22.5% | +15.9% | +5.9% |
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Elevance Health's carelonrx — cost of products sold?
- Elevance Health (ELV) reported carelonrx — cost of products sold of $9.83B in Q1 2026.
- How has Elevance Health's carelonrx — cost of products sold changed year-over-year?
- Elevance Health's carelonrx — cost of products sold increased by 5.9% year-over-year, from $9.28B to $9.83B.
- What is the long-term trend for Elevance Health's carelonrx — cost of products sold?
- Over 3 years (2022 to 2025), Elevance Health's carelonrx — cost of products sold has grown at a 14.7% compound annual growth rate (CAGR), from $26.54B to $40.08B.
- What does carelonrx — cost of products sold mean?
- The direct cost of purchasing the drugs and products sold by the pharmacy segment.